Qiao W - Search Results

1

Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study.

Ha MJ, Singareeka Raghavendra A, Kettner NM, Qiao W, Damodaran S, Layman RM, Hunt KK, Shen Y, Tripathy D, Keyomarsi K. Ha MJ, et al. Among authors: qiao w. Int J Cancer. 2022 Jun 15;150(12):2025-2037. doi: 10.1002/ijc.33959. Epub 2022 Mar 3. Int J Cancer. 2022. PMID: 35133007 Free PMC article.

2

Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate.

McAuliffe JC, Lazar AJ, Yang D, Steinert DM, Qiao W, Thall PF, Raymond AK, Benjamin RS, Trent JC. McAuliffe JC, et al. Among authors: qiao w. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6727-34. doi: 10.1158/1078-0432.CCR-07-0895. Clin Cancer Res. 2007. PMID: 18006774

3

A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis.

McAuliffe JC, Hunt KK, Lazar AJ, Choi H, Qiao W, Thall P, Pollock RE, Benjamin RS, Trent JC. McAuliffe JC, et al. Among authors: qiao w. Ann Surg Oncol. 2009 Apr;16(4):910-9. doi: 10.1245/s10434-008-0177-7. Epub 2008 Oct 25. Ann Surg Oncol. 2009. PMID: 18953611 Free PMC article. Clinical Trial.

4

Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.

Sharma R, Bedrosian I, Lucci A, Hwang RF, Rourke LL, Qiao W, Buchholz TA, Kronowitz SJ, Krishnamurthy S, Babiera GV, Gonzalez-Angulo AM, Meric-Bernstam F, Mittendorf EA, Hunt KK, Kuerer HM. Sharma R, et al. Among authors: qiao w. Ann Surg Oncol. 2010 Nov;17(11):2899-908. doi: 10.1245/s10434-010-1089-x. Epub 2010 May 5. Ann Surg Oncol. 2010. PMID: 20443145 Free PMC article.

5

The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.

Hatiboglu MA, Kong LY, Wei J, Wang Y, McEnery KA, Fuller GN, Qiao W, Davies MA, Priebe W, Heimberger AB. Hatiboglu MA, et al. Among authors: qiao w. Int J Cancer. 2012 Jul 1;131(1):8-17. doi: 10.1002/ijc.26307. Epub 2011 Aug 24. Int J Cancer. 2012. PMID: 21792892 Free PMC article.

6

Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.

Lin P, Dickason TJ, Fayad LE, Lennon PA, Hu P, Garcia M, Routbort MJ, Miranda R, Wang X, Qiao W, Medeiros LJ. Lin P, et al. Among authors: qiao w. Cancer. 2012 Mar 15;118(6):1566-73. doi: 10.1002/cncr.26433. Epub 2011 Aug 31. Cancer. 2012. PMID: 21882178 Free article.

7

Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma.

Manoukian GE, Tannir NM, Jonasch E, Qiao W, Haygood TM, Tu SM. Manoukian GE, et al. Among authors: qiao w. Clin Genitourin Cancer. 2011 Dec;9(2):81-8. doi: 10.1016/j.clgc.2011.07.001. Epub 2011 Oct 1. Clin Genitourin Cancer. 2011. PMID: 21958521 Free PMC article. Clinical Trial.

8

Impact of numerical variation in FMS-like tyrosine kinase receptor 3 internal tandem duplications on clinical outcome in normal karyotype acute myelogenous leukemia.

Borthakur G, Kantarjian H, Patel KP, Ravandi F, Qiao W, Faderl S, Kadia T, Luthra R, Pierce S, Cortes JE. Borthakur G, et al. Among authors: qiao w. Cancer. 2012 Dec 1;118(23):5819-22. doi: 10.1002/cncr.27571. Epub 2012 May 17. Cancer. 2012. PMID: 22605576 Free PMC article.

9

Response in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: analysis of three clinical trials.

Som A, Tu SM, Liu J, Wang X, Qiao W, Logothetis C, Corn PG. Som A, et al. Among authors: qiao w. Br J Cancer. 2012 Oct 23;107(9):1547-53. doi: 10.1038/bjc.2012.436. Epub 2012 Oct 2. Br J Cancer. 2012. PMID: 23033003 Free PMC article.

10

The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer.

Khalil MA, Qiao W, Carlson P, George B, Javle M, Overman M, Varadhachary G, Wolff RA, Abbruzzese JL, Fogelman DR. Khalil MA, et al. Among authors: qiao w. Invest New Drugs. 2013 Oct;31(5):1375-83. doi: 10.1007/s10637-013-9967-2. Epub 2013 May 4. Invest New Drugs. 2013. PMID: 23645398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,556 results

Search Page

Filters